AlphaRET aims to establish a multicentre to gain FDA clearance for 2RT to treat patients with intermediate stage AMD.
Get the most important news and business ideas for eyecare professionals every weekday from INVISION.
Tons of business ideas for eyecare professionals!
Advertisement